Immune modulation in the treatment of respiratory infection

Respiratory Research

Volumn 1, Issue 1, 2000, Pages 9-11

  Koll, Jay K ^a   Nelson, Steve ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Gene therapy; Immunotherapy; Pneumonia

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; PLACEBO; VACCINE;

ACID FAST BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTENSIVE CARE; LEUKOCYTE FUNCTION; LOBAR PNEUMONIA; LUNG LAVAGE; MORTALITY; MYCOBACTERIUM INTRACELLULARE AVIUM; NUTRITIONAL HEALTH; PATHOGENICITY; PHENOTYPE; RESPIRATORY TRACT INFECTION;

ADJUVANTS, IMMUNOLOGIC; CYTOKINES; HUMANS; RESPIRATORY TRACT INFECTIONS;

EID: 0034581473     PISSN: 14659921     EISSN: None     Source Type: Journal    
DOI: 10.1186/rr4     Document Type: Article

References (27)

1. Proportion of community-acquired pneumonia cases attributable to tobacco smoking
2. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults
3. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology
4. Evolving risk factors for infectious complications of cancer therapy
5. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
6. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial
7. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial
8. Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin
9. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
10. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
11. Exacerbation of acute and chronic murine tuberculosis by administration of a TNF receptor expressing adenovirus
12. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense
13. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response
14. Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration
15. Compartmentalized cytokine production within the human lung in unilateral pneumonia
16. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
17. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome
18. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial
19. Ventilator-induced injury: From barotrauma to biotrauma
20. Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment
21. Clinical aspects: From systemic inflammation to 'immunoparalysis'
22. Innate immunity, cytokines, pulmonary host defense
23. Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia
24. A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia
25. Time to resolution of morbidity: An endpoint for assessing the clinical cure of community-acquired pneumonia
26. Safety and feasibility of combined aersolized and subcutaneous interferon-gamma as adjuvant treatment of Mycobacterium avium complex pulmonary infection in non-HIV infected hosts
27. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol